Immunology: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • Immunol Curr Res 2022, Vol 6(1): 106
  • DOI: 10.4172/icr.1000106

Cxcl1 Chemokine as a Potential Disease Activity Marker in Systemic Lupus Erythematosus

Xiaowei Yang*
Department of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China
*Corresponding Author : Xiaowei Yang, Department of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China, Email: Xiaowei@gmail.com

Received Date: Jan 31, 2022 / Published Date: Feb 28, 2022

Abstract

 The chemokine CXCL1, referred to as growth-related transforming gene transforming gene (GRO-α), may be a potent chemoattractant and regulator of neutrophils. The aim of our study was to judge the restrictive response of CXCL1 within the serum of patients with general lupus erythroderma (SLE) within the active stage of malady and to assess whether or not it had been involved within the pathogenesis/ inflammatory method in lupus.

Keywords:  Cxcl1 Chemokine, Systemic Lupus Erythematosus

Citation: Yang X (2022) Cxcl1 Chemokine as a Potential Disease Activity Marker in Systemic Lupus Erythematosus. Immunol Curr Res, 6: 106. Doi: 10.4172/icr.1000106

Copyright: © 2022 Yang X. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top